These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15164616)

  • 1. [Effects of neurotensin microinjected into ventral tegmental area on spontaneous motor activity in neonatal 6-hydroxydopamine-treated rats].
    Ikegami M; Iwasaki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):83-5. PubMed ID: 15164616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compensatory increase in extracellular dopamine in the nucleus accumbens of adult rats with neonatal 6-hydroxydopamine treatment.
    Ikegami M; Ichitani Y; Takahashi T; Iwasaki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Jun; 26(3):111-7. PubMed ID: 16866211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
    Kalivas PW; Richardson-Carlson R; Duffy P
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1126-31. PubMed ID: 3755755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
    Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment.
    Brus R; Kostrzewa RM; Perry KW; Fuller RW
    J Pharmacol Exp Ther; 1994 Jan; 268(1):231-7. PubMed ID: 8301563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spontaneous motor activity and radial-maze learning in rats neonatally treated with 6-hydroxydopamine].
    Iwasaki T; Takasuna M
    Yakubutsu Seishin Kodo; 1986 Dec; 6(4):381-8. PubMed ID: 3103348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat.
    Kalivas PW; Burgess SK; Nemeroff CB; Prange AJ
    Neuroscience; 1983 Mar; 8(3):495-505. PubMed ID: 6406930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson's disease.
    Cass WA; Peters LE; Smith MP
    Brain Res; 2005 Feb; 1034(1-2):153-61. PubMed ID: 15713267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of neurotensin in positive reinforcement in the rat central nucleus of amygdala.
    László K; Tóth K; Kertes E; Péczely L; Lénárd L
    Behav Brain Res; 2010 Apr; 208(2):430-5. PubMed ID: 20035801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
    Zhang K; Davids E; Tarazi FI; Baldessarini RJ
    Psychopharmacology (Berl); 2002 Apr; 161(1):100-6. PubMed ID: 11967637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.
    Bauco P; Rompré PP
    Psychopharmacology (Berl); 2003 Jul; 168(3):253-61. PubMed ID: 12682711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
    J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine.
    Avale ME; Nemirovsky SI; Raisman-Vozari R; Rubinstein M
    J Neurosci Res; 2004 Oct; 78(2):289-96. PubMed ID: 15378510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive reinforcing effect of neurotensin microinjection into the ventral pallidum in conditioned place preference test.
    Ollmann T; Péczely L; László K; Kovács A; Gálosi R; Berente E; Karádi Z; Lénárd L
    Behav Brain Res; 2015 Feb; 278():470-5. PubMed ID: 25447302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Right/left discrimination learning in rat pups neonatally treated with 6-hydroxydopamine].
    Takasuna M; Iwasaki T
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):315-21. PubMed ID: 2123587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
    Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesolimbic dopamine mediates gastric mucosal protection by central neurotensin.
    Xing LP; Balaban C; Seaton J; Washington J; Kauffman G
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G34-8. PubMed ID: 1899007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different adaptations in ventral tegmental area dopamine neurons in control and ethanol exposed rats after methylphenidate treatment.
    Shen RY; Choong KC
    Biol Psychiatry; 2006 Apr; 59(7):635-42. PubMed ID: 16199009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neurotensin administered into the ventral tegmental area on prepulse inhibition of startle.
    Feifel D; Reza TL
    Behav Brain Res; 1999 Dec; 106(1-2):189-93. PubMed ID: 10595435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.